Saliva / Oral Fluid Drug Testing for Cannabis

Oral fluid (saliva) testing detects parent Δ9-THC directly in the mouth. It has a much shorter detection window than urine testing — typically 12 to 72 hours — but a better relationship to recent use. Oral fluid testing is growing rapidly and is authorized (but not yet operational) for DOT workplace drug testing.

Sealed oral fluid swab pouch on a plain white test card

What Oral Fluid Tests Detect

Oral fluid tests measure parent Δ9-THC directly, not THC-COOH. When cannabis is smoked or vaped, some THC is deposited in the oral cavity and mixes with saliva. This oral-cavity deposition is the primary source of detectable THC in oral fluid after inhalation.

For edible cannabis, there is no oral cavity deposition (or very little), so oral fluid THC levels are substantially lower after oral administration than after smoking at the same dose. This is relevant for anyone whose primary use is edibles.

SAMHSA Cutoffs for Oral Fluid

SAMHSA's Oral Fluid Mandatory Guidelines (OFMG), effective October 10, 2023:

Initial screen: 4 ng/mL THC
Confirmation: 2 ng/mL THC

These cutoffs are dramatically lower than urine cutoffs because oral fluid concentrations are much lower to begin with. Do not confuse a 2 ng/mL oral fluid cutoff with the 5 ng/mL blood per se limits used in some DUI statutes — different matrices, different meanings.

Detection Window

Usage Pattern	Detection Window
Single use (smoked)	12–24 hours
Occasional	24–48 hours
Regular	24–72 hours
Heavy/daily	Up to 72 hours
Chronic heavy	Up to 72+ hours (variable)
Edibles only	Substantially lower / may not detect

The window is much narrower than urine testing because oral fluid THC is primarily from recent inhalation deposits rather than from sustained metabolite excretion.

DOT Oral Fluid Testing Status

The Department of Transportation authorized oral fluid testing as an alternative to urine via a final rule effective December 5, 2024. This was a significant policy shift — DOT had been urine-only for decades.

However, DOT oral fluid testing is not yet operationally available. The rule requires at least two HHS-certified oral fluid labs before the program can go live. As of April 2026, zero U.S. laboratories have been certified for federal oral fluid testing. Implementation has repeatedly slipped.

Rapidly Evolving

DOT oral fluid testing could begin once the first labs are certified, likely during 2026 or 2027. This will be a significant change for CDL drivers, pilots, and other DOT-regulated workers — oral fluid testing will detect much more recent use than urine testing.

Where Oral Fluid Testing Is Currently Used

Private employers outside federal regulation — increasingly common, especially for pre-employment
Some roadside DUI investigations — a few states and Canadian provinces use oral fluid screening devices
Probation and reasonable-suspicion testing — where rapid point-of-care results are valued
Research studies — convenient for repeat sampling
Professional sports — some leagues use oral fluid for in-competition testing

Collection Procedure

Oral fluid collection uses a collection device placed in the donor's mouth for a specified period (typically 1–5 minutes). Modern devices include:

Quantisal (Immunalysis) — lab-based with oral fluid collection
Intercept i2 (OraSure) — common lab device
Dräger DrugTest 5000 — point-of-care roadside device
Alere DDS2 — roadside point-of-care

The collection is directly observed because the donor is holding the device in their mouth. This makes oral fluid testing much harder to adulterate than urine testing.

Advantages of Oral Fluid

Shorter, more recent-use-relevant window than urine
Observable collection eliminates most adulteration and substitution
Non-invasive compared to blood
Detects parent THC, which has a closer relationship to impairment than urinary metabolites
Point-of-care devices can give results in minutes

Limitations

Oral cavity contamination — recent cannabis smoking produces high THC in oral fluid even if no meaningful amount entered systemic circulation
Edibles produce lower oral fluid concentrations, which can lead to missed detection of real impairment from edibles
Not yet operationally available for DOT testing
Point-of-care devices vary in reliability
Passive exposure can theoretically cause detectable levels at very low cutoffs, though studies suggest this is rarely a real-world problem at the SAMHSA confirmation threshold

Cost

Point-of-care oral fluid screening: $15–40 per test
Lab-based oral fluid with confirmation: $40–100